Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,928 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elucidating the Synergistic Effect of Multiple Chinese Herbal Prescriptions in the Treatment of Post-stroke Neurological Damage.
Xu A, Wen ZH, Su SX, Chen YP, Liu WC, Guo SQ, Li XF, Zhang X, Li R, Xu NB, Wang KX, Li WX, Guan DG, Duan CZ. Xu A, et al. Among authors: xu nb. Front Pharmacol. 2022 Mar 9;13:784242. doi: 10.3389/fphar.2022.784242. eCollection 2022. Front Pharmacol. 2022. PMID: 35355727 Free PMC article.
Based on the enriched pathways, molecular docking, and network analysis results, we constructed a complex network containing 3 prescriptions, 14 botanical drugs, 26 compounds, 13 targets, and 5 pathways. ...Conclusion: By integrating pharmacological and chemoinformatic app …
Based on the enriched pathways, molecular docking, and network analysis results, we constructed a complex network containing 3 prescr …
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors.
Nelson BE, O'Brien S, Sheth RA, Hong DS, Naing A, Zhang X, Xu A, Hamuro L, Suryawanshi R, McKinley D, Novosiadly RD, Piha-Paul SA. Nelson BE, et al. Among authors: xu a. J Immunother Cancer. 2025 Jan 16;13(1):e010013. doi: 10.1136/jitc-2024-010013. J Immunother Cancer. 2025. PMID: 39824531 Clinical Trial.
4,928 results